Dashboard
Manage Tickers

NTRNutrien Ltd.

NYSE nutrien.com


$ 47.91 $ -1.97 (-3.95 %)    

Friday, 02-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 47.92
$ 47.91 x 300
$ 47.93 x 100
-- - --
$ 46.44 - $ 65.81
2,077,544
na
23.82B
$ 0.80
$ 8.98
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-nutrien-lowers-price-target-to-66
Wells Fargo Maintains Overweight on Nutrie...
07/16/2024 13:54:38

Wells Fargo analyst Richard Garchitorena maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $68...

rbc-capital-maintains-outperform-on-nutrien-lowers-price-target-to-60
RBC Capital Maintains Outperform on Nutrie...
07/15/2024 15:46:15

RBC Capital analyst Andrew Wong maintains Nutrien (NYSE:NTR) with a Outperform and lowers the price target from $70 to $60.

ubs-maintains-buy-on-nutrien-lowers-price-target-to-66
UBS Maintains Buy on Nutrien, Lowers Price...
07/09/2024 21:07:59

UBS analyst Joshua Spector maintains Nutrien (NYSE:NTR) with a Buy and lowers the price target from $67 to $66.

nutrien-shares-are-trading-higher-after-pricing-a-senior-notes-offering
Nutrien shares are trading higher after pr...
06/18/2024 13:03:12

reported-earlier-nutrien-sets-pricing-for-1b-dual-tranche-senior-notes-offering-aims-for-debt-refinancing
Reported Earlier, Nutrien Sets Pricing For...
06/18/2024 09:06:19

Nutrien Ltd. (NYSE:NTR) today announced the pricing of US$400 million aggregate principal amount of 5.200 percent senior notes ...

celsius-and-paypal-were-among-the-10-biggest-large-cap-losers-last-week-june-9-june-15-are-these-in-your-portfolio
Celsius And PayPal Were Among The 10 Bigge...
06/16/2024 17:48:47

10 worst performers in last week: Celsius Holdings, Gold Fields, Paramount Global, Warner Bros. Discovery, PayPal, Samsara, Ora...

Core News & Articles
Nutrien Says It Is Trying To Grow Its Seed...
06/12/2024 15:52:37

- Reuters

nutrien-ceo-says-co-pursuing-divestiture-of-retail-assets-in-argentina-chile-uruguay-co-will-continue-to-review-its-footprint-to-drive-down-operating-costs-across-its-brazilian-business-expects-a-continuous-rise-in-costs-alongside-a-rise-in-global-demand-says-retail-assets-in-argentina-chile-and-uruguay-have-accounted-for-around-2-of-retail-earnings
Nutrien CEO Says Co Pursuing Divestiture O...
06/12/2024 15:01:43

- Reuters

nutrien-to-highlight-strategic-priorities-and-2026-targets-at-investor-day-today-at-1000-am-et-targeting-retail-adjusted-ebitda-of-19b-21b-in-2026-including-a-goal-of-14b-in-gross-margin-from-proprietary-products-portfolio-intends-to-reduce-controllable-costs-across-operations-and-corporate-functions-by-200m-and-maintain-annual-average-capital-expenditures-of-22b-23b-through-2026
Nutrien To Highlight Strategic Priorities ...
06/12/2024 12:43:59

Strategic Priorities and Performance TargetsSimplifying portfolio and focusing on core assets and markets to enhance earnings q...

piper-sandler-maintains-underweight-on-nutrien-lowers-price-target-to-55
Piper Sandler Maintains Underweight on Nut...
06/11/2024 17:18:34

Piper Sandler analyst Charles Neivert maintains Nutrien (NYSE:NTR) with a Underweight and lowers the price target from $56 t...

piper-sandler-maintains-underweight-on-nutrien-raises-price-target-to-56
Piper Sandler Maintains Underweight on Nut...
05/17/2024 13:01:46

Piper Sandler analyst Charles Neivert maintains Nutrien (NYSE:NTR) with a Underweight and raises the price target from $54 t...

mizuho-maintains-underweight-on-nutrien-raises-price-target-to-56
Mizuho Maintains Underweight on Nutrien, R...
05/17/2024 12:22:03

Mizuho analyst Christopher Parkinson maintains Nutrien (NYSE:NTR) with a Underweight and raises the price target from $54 to...

wells-fargo-maintains-overweight-on-nutrien-raises-price-target-to-68
Wells Fargo Maintains Overweight on Nutrie...
05/10/2024 15:52:49

Wells Fargo analyst Richard Garchitorena maintains Nutrien (NYSE:NTR) with a Overweight and raises the price target from $67...

mizuho-maintains-neutral-on-nutrien-raises-price-target-to-59
Mizuho Maintains Neutral on Nutrien, Raise...
05/09/2024 12:00:31

Mizuho analyst Christopher Parkinson maintains Nutrien (NYSE:NTR) with a Neutral and raises the price target from $54 to $59.

nutrien-sees-fy24-retail-adj-ebitda-165b-185b
Nutrien Sees FY24 Retail Adj. EBITDA $1.65...
05/08/2024 21:58:09

nutrien-q1-2024-adj-eps-046-beats-037-estimate-sales-5389b-beat-5315b-estimate
Nutrien Q1 2024 Adj EPS $0.46 Beats $0.37 ...
05/08/2024 21:51:54

Nutrien (NYSE:NTR) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.37 by 24.32 p...

berenberg-upgrades-nutrien-to-buy-raises-price-target-to-66
Berenberg Upgrades Nutrien to Buy, Raises ...
04/29/2024 09:34:33

Berenberg analyst Aron Ceccarelli upgrades Nutrien (NYSE:NTR) from Hold to Buy and raises the price target from $60 to $66.

nutrien-mulls-latam-divestments-after-losses-management-exodus
"Nutrien Mulls Latam Divestments After Los...
03/28/2024 17:25:50

- Reuters News 

jefferies-initiates-coverage-on-nutrien-with-buy-rating-announces-price-target-of-62
Jefferies Initiates Coverage On Nutrien wi...
03/26/2024 09:38:20

Jefferies analyst Laurence Alexander initiates coverage on Nutrien (NYSE:NTR) with a Buy rating and announces Price Target o...

wolfe-research-initiates-coverage-on-nutrien-with-outperform-rating
Wolfe Research Initiates Coverage On Nutri...
03/01/2024 10:54:56

Wolfe Research analyst Chris Parkinson initiates coverage on Nutrien (NYSE:NTR) with a Outperform rating.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)